VERTEX PHARMACEUTICALS INC / MA (VRTX) has 12 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $2.8M. Most recent filing: Sept. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 10, 2026 filed Sept. 8, 2026 | van Grunsven Jasper EVP, CP and NPPO | $0 | 8,682 | New | No | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 28, 2026 | Ambrose Kristen SVP & Chief Accounting Officer | $0 | 5,000 | +75% | No | |
|
|
||||||
| Aug. 31, 2026 filed Aug. 27, 2026 | SACHS BRUCE I Director | $0 | 6,000 | −13% | No | |
|
|
||||||
| July 23, 2026 filed July 21, 2026 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | $0 | 8,251 | +18% | No | |
|
|
||||||
| July 23, 2026 filed July 21, 2026 | Sachdev Amit EVP Chief Patient & Ext Af Off | $0 | 8,251 | +14% | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free